Sitemap - 2022 - On Drugs

When Patents Met Regulations

GHB, Orphans, and REMS: A Regulatory Love Story (Part 1)

Garbage from NYU Langone

An Open Letter to Governor and Former DEA Administrator Asa Hutchinson

DXM: An Odd Drug Control Duck

President Biden's Scheduling Directive Part 3

President Biden's Scheduling Directive Part 2

President Biden's Scheduling Directive Is a Game Changer

Reminder: Marijuana Possession--Still a Federal Crime

Matt Presents on Patents

Three Fever Thoughts As the World Turnbulls

Schedule VI

Words on the Five Tryptamines Matter

Psychedelic Patent Wars 3: Nuthin' But a 'K' Thang

Turning Water Into Weed And Other Absurdities

What I've Been Doing...

The Great American Drug Machine™

The Road Ahead

The On Drugs Library

Hot Psilocybin Patent Garbage: Keep it Burnin'

Psychedelic Patent Wars 2: Lost at the Patent Office (Part 2)

Psychedelic Patent Wars 2: Lost at the Patent Office (Part 1)

Hot Psilocybin Patent Garbage

Ninth Circuit Says Intoxicating Delta 8 Hemp Products Are Legal

Fixing The Analogue Act

Revisionist History

The Medical Marijuana Research Act (H.R. 5657)

The Source Rule Is Dead

The Minority Report

The Cannabidiol and Marihuana Research Expansion Act (S. 253)

Exploring the Legalities of Trip Sitting

America's Exit Drugs

The Mushroom Rabbi: A RFRA Riff

PCP: Proof We Don't Need Schedule I

The Hemp Advancement Act and the 167:1 Problem

The Music Isn't In Them

Purely Intrastate: Local Cannabis and Entheogenic Plant Operations

Maybe San Pedro isn't controlled?

A Nine Plant Bust in Indian Country

From "Crack Houses" to "Safehouses": DEA's Untapped Power to Save Lives